Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study

Published:2010-10 Issue:10 Volume:53 Page:1432-1438
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

Ahmed Shahid,Ahmad Imran,Zhu Tong,Arnold Florence P.,Faiz Anan Ghadeer,Sami Amer,Yadav Sunil K.,Alvi Riaz,Haider Kamal

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference22 articles.

1. Controlled trial of flurouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.;O'Connell;J Clin Oncol,1997

2. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III COLON CANCER in the MOSAIC Trial.;Andre;J Clin Oncol,2009

3. Preoperative versus postoperative chemoradiotherapy for rectal cancer.;Sauer;N Engl J Med,2004

4. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.;O'Connell;N Engl J Med,1994

5. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.;Chau;Ann Oncol,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan;BMC Cancer;2023-09-25

2. The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer;BMC Cancer;2023-05-09

3. Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials;Journal of Clinical Oncology;2023-02-01

4. New Insights into Adjuvant Therapy for Localized Colon Cancer;Hematology/Oncology Clinics of North America;2022-06

5. Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?;British Journal of Clinical Pharmacology;2022-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3